Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07676084 · ClinicalTrials.gov registry record · Phase 4
Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease
A Phase 4 study, sponsored by Andover Research Eye Institute.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT07676084 is a Phase 4 study that is actively recruiting participants, run by Andover Research Eye Institute. The registered enrollment target is 60 participants.
The verdict
NCT07676084, a Phase 4 study, is actively recruiting participants, sponsored by Andover Research Eye Institute.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
A study to evaluate the effect of over- the- counter (OTC) lubricating eye drops on tolerability, symptoms and visual outcomes in patients with dry eye disease (DED)
Interventions
- DRUG Preservative Free Polyethylene glycol 400 0.25%
- DRUG Propylene Glycol (0.6%)
- DRUG Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-06-03 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07676084
The ClinicalTrials.gov registry entry for NCT07676084 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Andover Research Eye Institute, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Preservative Free Polyethylene glycol 400 0.25% is the first listed.
NCT07676084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07676084 about?
NCT07676084 is a clinical study titled "Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease". A study to evaluate the effect of over- the- counter (OTC) lubricating eye drops on tolerability, symptoms and visual outcomes in patients with dry eye disease (DED)
What is the current status of trial NCT07676084?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2026-06-03. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07676084?
The interventions under investigation include: Preservative Free Polyethylene glycol 400 0.25% (DRUG), Propylene Glycol (0.6%) (DRUG), Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5% (DRUG).
Who is sponsoring clinical trial NCT07676084?
This trial is sponsored by Andover Research Eye Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.